75430-97-6Relevant articles and documents
Interaction of aryl tetrazolones with anions: proton transfervs.hydrogen bonding
Nord, Erika,Rayat, Sundeep,Zhou, Hanyang
supporting information, p. 14184 - 14192 (2021/08/16)
In this study, the interaction of two monosubstituted aryl tetrazolones, namely 1-(4-nitrophenyl)-1,4-dihydro-tetrazol-5-one1aand 1-(4-trifluoromethylphenyl)-1,4-dihydro-tetrazol-5-one1b, with anions of varying basicitye.g.hydrogen sulfate (HSO4?), bromide (Br?), nitrate (NO3?), thiocyanate (NCS?), chloride (Cl?) and acetate (AcO?) was investigated in acetonitrile and DMSO. UV and NMR titrations indicated that tetrazolones interact through hydrogen bonding or weak electrostatic interactions with HSO4?, Br?, NO3?, NCS?, and Cl?. The association constants (Ka) were found to be in the order Cl?> Br?> NO3?> NCS?> HSO4?. Tetrazolones1a,bexhibited almost 9 times higher selectivity towards Cl?compared to Br?which may be attributed to the higher basicity of the former. The affinity of1atowards most anions was higher than1b, except for HSO4?. This was attributed to the higher electron withdrawing ability of the -NO2group compared to -CF3that renders the N-H proton more acidic for interaction with anions resulting in higherKavalues. Significant UV changes were observed upon addition of the AcO?anion to the solution of1a,bin acetonitrile as new bands formed and isosbestic points were observed indicating the formation of a new species. NMR titrations in DMSO-d6further confirmed that1a,bunderwent deprotonation with AcO?owing to its higher basicity.
Reactions of dimethyl 2-chloroethynylphosphonate with 1-substituted 5-oxo-1H-1,2,3,4-tetrazoles
Mel'nikova,Myznikov,Dogadina,Svintsitskaya
, p. 2160 - 2166 (2015/02/02)
Addition of 1-substituted tetrazol-5-ones to dimethyl 2-chloroethynylphosphonate occurred regioselectively to form new geminally substituted bis(4-R-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethenylphosphonates with 65- 92% yield.
NOVEL SULFONAMIDE SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS
-
Page/Page column 28, (2008/12/07)
This invention relates to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.